<DOC>
	<DOC>NCT00758069</DOC>
	<brief_summary>A clinical study determines the safety and efficacy of sitagliptin (MK0431) in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy</brief_summary>
	<brief_title>Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients Have Type 2 Diabetes Mellitus On Diet/Exercise Therapy Patients Have Type 1 Diabetes Mellitus</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>